Cargando…
Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection
BACKGROUND AND AIM: In acute severe COVID-19, patients present with lung inflammation and vascular injury, accompanied by an exaggerated cytokine response. In this study, our aim was to describe the inflammatory and vascular mediator profiles in patients who were previously hospitalized with COVID-1...
Autores principales: | Melhorn, James, Alamoudi, Asma, Mentzer, Alexander J., Fraser, Emily, Fries, Anastasia, Cassar, Mark Philip, Kwok, Andrew, Knight, Julian Charles, Raman, Betty, Talbot, Nick P, Petousi, Nayia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950100/ https://www.ncbi.nlm.nih.gov/pubmed/36844209 http://dx.doi.org/10.3389/fmed.2023.1056506 |
Ejemplares similares
-
Symptom Persistence Despite Improvement in Cardiopulmonary Health – Insights from longitudinal CMR, CPET and lung function testing post-COVID-19
por: Cassar, Mark Philip, et al.
Publicado: (2021) -
Human adaptation to the hypoxia of high altitude: the Tibetan paradigm from the pregenomic to the postgenomic era
por: Petousi, Nayia, et al.
Publicado: (2013) -
Interferon-β-induced pulmonary sarcoidosis in a 30-year-old woman treated for multiple sclerosis: a case report
por: Petousi, Nayia, et al.
Publicado: (2012) -
Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia
por: Xu, Haopeng, et al.
Publicado: (2022) -
Human hypoxic pulmonary vasoconstriction is unaltered by 8 h of preceding isocapnic hyperoxia
por: Cheng, Hung‐Yuan, et al.
Publicado: (2017)